ARCA Biopharma - 23 Year Stock Price History | ABIO

Historical daily share price chart and data for ARCA Biopharma since 1997 adjusted for splits. The latest closing stock price for ARCA Biopharma as of May 29, 2020 is 12.60.
  • The all-time high ARCA Biopharma stock closing price was 318274.69 on February 18, 2000.
  • The ARCA Biopharma 52-week high stock price is 22.00, which is 74.6% above the current share price.
  • The ARCA Biopharma 52-week low stock price is 2.21, which is 82.5% below the current share price.
  • The average ARCA Biopharma stock price for the last 52 weeks is 5.29.
ARCA Biopharma Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.4365 5.6800 19.2100 2.3200 12.6000 120.64%
2019 4.8113 0.3300 15.1000 0.3300 5.7107 1612.35%
2018 0.7346 1.3500 1.9000 0.2800 0.3335 -75.30%
2017 1.9933 2.7100 2.8500 1.0500 1.3500 -52.63%
2016 3.1555 4.6400 4.7800 2.1500 2.8500 -38.71%
2015 5.9538 7.2778 10.5668 4.6074 4.6500 -30.32%
2014 10.1900 12.1064 15.8160 4.9685 6.6732 -43.24%
2013 13.5113 17.2114 36.2279 8.3975 11.7565 -26.30%
2012 23.9733 41.9790 43.6582 9.6552 15.9520 -62.00%
2011 78.4740 132.2339 138.1109 41.5382 41.9790 -68.45%
2010 155.5109 137.6911 345.0758 110.8246 133.0735 -2.76%
2009 194.7055 268.6657 564.6177 94.4528 136.8516 -47.42%
2008 625.7693 1494.4527 1553.2233 209.8950 260.2698 -83.06%
2007 2343.0976 3182.0088 4768.8153 1074.6626 1536.4317 -54.25%
2006 13860.8663 7161.6188 17379.3093 3274.3626 3358.3206 -50.68%
2005 6802.5983 8269.8646 8672.8630 4894.7523 6808.9951 -17.66%
2004 8841.5340 9068.3726 13753.6984 6212.8932 8269.8646 -6.20%
2003 5110.4558 2090.7637 10327.8687 1788.4846 8816.4733 302.30%
2002 7974.9100 20479.4080 21814.4740 2191.5234 2191.5234 -88.75%
2001 26260.4955 36878.0484 43502.9984 13854.4581 19471.8111 -46.28%
2000 95399.7392 39397.0408 318274.6869 30555.3775 36248.3003 -15.40%
1999 11906.9371 12594.9619 45694.5217 6549.3802 42848.0603 224.00%
1998 22272.3908 23955.6175 37507.7965 10705.7176 13224.7100 -45.48%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.020B $0.000B
ARCA biopharma, Inc., a biopharmaceutical company, develops genetically-targeted therapies for heart failure and cardiovascular diseases. It is positioned to bring personalized therapies for the treatment of cardiovascular disease, through the use of genetics. Complementing the Company's cardiovascular science, ARCA's management team has significant experience in developing and commercializing cardiovascular products. The Company's business focus combines expertise in cardiovascular pathophysiology, molecular genetics, clinical development and product commercialization. It is currently developing Gencaro (bucindolol hydrochloride), a cardiovascular drug for the treatment of chronic heart failure. The company is based in Broomfield, Colorado.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $135.120B 14.88
Gilead Sciences (GILD) United States $97.628B 12.65
CSL (CSLLY) Australia $84.053B 0.00
Vertex Pharmaceuticals (VRTX) United States $74.661B 51.33
Regeneron Pharmaceuticals (REGN) United States $67.420B 25.99
Illumina (ILMN) United States $53.368B 54.84
Biogen (BIIB) United States $50.113B 8.58
Seattle Genetics (SGEN) United States $27.213B 0.00
Alexion Pharmaceuticals (ALXN) United States $26.477B 11.38
Moderna (MRNA) United States $22.830B 0.00
Incyte (INCY) United States $22.153B 0.00
Genmab (GMAB) Denmark $19.891B 16.38
Genmab (GNMSF) Denmark $19.309B 57.33
BioMarin Pharmaceutical (BMRN) United States $19.268B 174.67
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $18.882B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.532B 0.00
Bio-Rad Laboratories (BIO.B) United States $13.825B 62.93
Galapagos (GLPG) Belgium $13.144B 38.92
Exact Sciences (EXAS) United States $12.860B 0.00
BeiGene (BGNE) Cayman Islands $12.803B 0.00
Sarepta Therapeutics (SRPT) United States $11.875B 0.00
BioNTech SE (BNTX) Germany $11.207B 0.00
Bio-Techne Corp (TECH) United States $10.121B 66.87
QIAGEN (QGEN) Netherlands $9.973B 29.00
Horizon Therapeutics Public (HZNP) Ireland $9.678B 23.82
ARGENX SE-ADR (ARGX) Netherlands $9.384B 0.00
Guardant Health (GH) United States $8.549B 0.00
Immunomedics (IMMU) United States $7.756B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.743B 0.00
Exelixis (EXEL) United States $7.578B 26.57
Ascendis Pharma (ASND) Denmark $6.981B 0.00
Repligen (RGEN) United States $6.850B 120.16
Acceleron Pharma (XLRN) United States $5.319B 0.00
Adaptive Biotechnologies (ADPT) United States $4.911B 0.00
Reata Pharmaceuticals (RETA) United States $4.830B 0.00
MyoKardia (MYOK) United States $4.775B 0.00
Emergent Biosolutions (EBS) United States $4.377B 28.69
China Biologic Products (CBPO) China $4.360B 24.24
Mirati Therapeutics (MRTX) United States $4.329B 0.00
Zai Lab (ZLAB) China $4.323B 0.00
Global Blood Therapeutics (GBT) United States $4.261B 0.00
MorphoSys AG (MOR) Germany $4.259B 33.03
Ultragenyx Pharmaceutical (RARE) United States $4.084B 0.00
Vir Biotechnology (VIR) United States $4.030B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.941B 86.11
Momenta Pharmaceuticals (MNTA) United States $3.705B 0.00
Bluebird Bio (BLUE) United States $3.541B 0.00
Blueprint Medicines (BPMC) United States $3.530B 0.00
Halozyme Therapeutics (HALO) United States $3.296B 0.00
Deciphera Pharmaceuticals (DCPH) United States $3.272B 0.00
Amicus Therapeutics (FOLD) United States $3.214B 0.00
Arena Pharmaceuticals (ARNA) United States $3.009B 0.00
UniQure (QURE) Netherlands $2.976B 0.00
Denali Therapeutics (DNLI) United States $2.940B 0.00
NeoGenomics (NEO) United States $2.811B 205.31
Novavax (NVAX) United States $2.668B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Alkermes (ALKS) Ireland $2.597B 51.13
Alector (ALEC) United States $2.584B 0.00
Fate Therapeutics (FATE) United States $2.520B 0.00
Insmed (INSM) United States $2.454B 0.00
Viela Bio (VIE) United States $2.392B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.380B 0.00
Inovio Pharmaceuticals (INO) United States $2.332B 0.00
Principia Biopharma (PRNB) United States $2.111B 0.00
Eidos Therapeutics (EIDX) United States $1.885B 0.00
Epizyme (EPZM) United States $1.774B 0.00
Zymeworks (ZYME) Canada $1.736B 0.00
Adverum Biotechnologies (ADVM) United States $1.657B 0.00
Ligand Pharmaceuticals (LGND) United States $1.630B 63.48
Dicerna Pharmaceuticals (DRNA) United States $1.594B 0.00
Sangamo Therapeutics (SGMO) United States $1.576B 0.00
Twist Bioscience (TWST) United States $1.555B 0.00
Zealand Pharma (ZEAL) Denmark $1.514B 0.00
PHARMA MAR SA (PHMMF) Spain $1.514B 0.00
Akcea Therapeutics (AKCA) United States $1.506B 0.00
Mesoblast (MESO) Australia $1.490B 0.00
Editas Medicine (EDIT) United States $1.489B 0.00
Arcus Biosciences (RCUS) United States $1.444B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.440B 0.00
I-Mab (IMAB) China $1.423B 0.00
Zealand Pharma (ZLDPF) Denmark $1.412B 0.00
REGENXBIO (RGNX) United States $1.403B 0.00
Intra-Cellular Therapies (ITCI) United States $1.387B 0.00
NGM Biopharmaceuticals (NGM) United States $1.344B 0.00
Mersana Therapeutics (MRSN) United States $1.335B 0.00
Coherus BioSciences (CHRS) United States $1.322B 9.23
Beam Therapeutics (BEAM) United States $1.315B 0.00
Arvinas (ARVN) United States $1.303B 0.00
Cytokineticsorporated (CYTK) United States $1.232B 0.00
Revance Therapeutics (RVNC) United States $1.192B 0.00
Myriad Genetics (MYGN) United States $1.083B 55.88
Nabriva Therapeutics AG (NBRV) Ireland $1.079B 0.00
Sorrento Therapeutics (SRNE) United States $1.059B 0.00
Compugen (CGEN) Israel $1.053B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.959B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.924B 0.00
Pharming Group (PHGUF) Netherlands $0.908B 0.00
Intellia Therapeutics (NTLA) United States $0.900B 0.00
Athenex (ATNX) United States $0.887B 0.00
NextCure (NXTC) United States $0.859B 0.00
Heska (HSKA) United States $0.826B 0.00
Cue Biopharma (CUE) United States $0.787B 0.00
Cellectis S.A (CLLS) France $0.784B 0.00
Alcobra (ARCT) United States $0.775B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.752B 0.00
Cara Therapeutics (CARA) United States $0.743B 0.00
Codexis (CDXS) United States $0.733B 0.00
Kadmon Holdings (KDMN) United States $0.711B 0.00
Retrophin (RTRX) United States $0.677B 0.00
Kala Pharmaceuticals (KALA) United States $0.672B 0.00
NantKwest (NK) United States $0.664B 0.00
Castle Biosciences (CSTL) United States $0.662B 0.00
Vericel (VCEL) United States $0.649B 119.83
Vanda Pharmaceuticals (VNDA) United States $0.639B 5.48
Morphic Holding (MORF) United States $0.636B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.634B 0.00
Bellus Health (BLU) Canada $0.632B 0.00
Agenus (AGEN) United States $0.624B 0.00
Stemline Therapeutics (STML) United States $0.624B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.585B 0.00
Frequency Therapeutics (FREQ) United States $0.576B 0.00
Athersys (ATHX) United States $0.572B 0.00
Dynavax Technologies (DVAX) United States $0.564B 0.00
MeiraGTx Holdings (MGTX) United States $0.554B 0.00
Scholar Rock Holding (SRRK) United States $0.550B 0.00
DBV Technologies S.A (DBVT) France $0.533B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.533B 0.00
Clovis Oncology (CLVS) United States $0.532B 0.00
AC Immune SA (ACIU) Switzerland $0.523B 0.00
AnaptysBio (ANAB) United States $0.520B 0.00
VBI Vaccines (VBIV) United States $0.503B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.503B 0.00
UROGEN PHARMA (URGN) United States $0.490B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.479B 0.00
BioDelivery Sciences (BDSI) United States $0.478B 25.16
Anika Therapeutics (ANIK) United States $0.476B 15.31
Aquinox Pharmaceuticals (NLTX) United States $0.467B 0.00
Protagonist Therapeutics (PTGX) United States $0.454B 0.00
Syros Pharmaceuticals (SYRS) United States $0.447B 0.00
Prothena (PRTA) Ireland $0.425B 0.00
CytomX Therapeutics (CTMX) United States $0.407B 0.00
Puma Biotechnology (PBYI) United States $0.402B 0.00
Albireo Pharma (ALBO) United States $0.401B 0.00
Seres Therapeutics (MCRB) United States $0.399B 0.00
MiMedx (MDXG) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.393B 0.00
PDL BioPharma (PDLI) United States $0.381B 327.00
ANI Pharmaceuticals (ANIP) United States $0.376B 7.45
Intrexon (PGEN) United States $0.375B 0.00
Precision BioSciences (DTIL) United States $0.364B 0.00
WAVE Life Sciences (WVE) Singapore $0.355B 0.00
Kamada (KMDA) Israel $0.349B 14.54
Avid Bioservices (CDMO) United States $0.330B 0.00
Geron (GERN) United States $0.327B 0.00
Menlo Therapeutics (MNLO) United States $0.326B 0.00
MannKind (MNKD) United States $0.322B 0.00
Selecta Biosciences (SELB) United States $0.321B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.316B 0.00
OSMOTICA PHARM (OSMT) United States $0.308B 0.00
Verastem (VSTM) United States $0.302B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
ADMA Biologics Inc (ADMA) United States $0.284B 0.00
Abeona Therapeutics (ABEO) United States $0.277B 0.00
Cellular Biomedicine (CBMG) United States $0.267B 0.00
Aduro Biotech (ADRO) United States $0.264B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.264B 0.00
Liquidia Technologies (LQDA) United States $0.262B 0.00
Starpharma Holdings (SPHRY) Australia $0.259B 0.00
Affimed (AFMD) Germany $0.251B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.246B 0.00
Spero Therapeutics (SPRO) United States $0.243B 0.00
Prometic Life Sciences (LMNL) Canada $0.242B 0.00
Exicure (XCUR) United States $0.241B 0.00
Gritstone Oncology (GRTS) United States $0.241B 0.00
Fortress Biotech (FBIO) United States $0.239B 0.00
HOOKIPA Pharma (HOOK) United States $0.238B 0.00
Northwest Biotherapeutics (NWBO) United States $0.234B 0.00
Sutro Biopharma (STRO) United States $0.233B 0.00
XOMA (XOMA) United States $0.227B 0.00
POXEL SA FRANCE (PXXLF) France $0.219B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.204B 3.08
ARAVIVE, INC (ARAV) United States $0.204B 0.00
IVERIC Bio (ISEE) United States $0.202B 0.00
Pluristem Therapeutics (PSTI) Israel $0.200B 0.00
GENFIT S.A (GNFT) France $0.197B 0.00
VTv Therapeutics (VTVT) United States $0.195B 0.00
Five Prime Therapeutics (FPRX) United States $0.194B 0.00
Cerecor (CERC) United States $0.193B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.192B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.188B 0.00
Strongbridge Biopharma (SBBP) United States $0.186B 0.00
Aytu Bioscience (AYTU) United States $0.179B 0.00
Antibe Therapeutics (ATBPF) Canada $0.173B 0.00
PHASEBIO PHARMA (PHAS) United States $0.173B 0.00
Aptinyx (APTX) United States $0.171B 0.00
Kindred Biosciences (KIN) United States $0.169B 0.00
Dyadic (DYAI) United States $0.167B 0.00
Orgenesis (ORGS) United States $0.160B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.159B 0.00
Celyad SA (CYAD) Belgium $0.158B 0.00
TELA Bio (TELA) United States $0.157B 0.00
Arbutus Biopharma (ABUS) Canada $0.150B 0.00
Cidara Therapeutics (CDTX) United States $0.148B 0.00
Biofrontera AG (BFRA) Germany $0.146B 0.00
Trevena (TRVN) United States $0.139B 0.00
Theratechnologies (THTX) Canada $0.139B 0.00
Enzo Biochem (ENZ) United States $0.136B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.131B 0.00
Applied Genetic Technologies (AGTC) United States $0.124B 0.00
AIT Therapeutics (XAIR) United States $0.120B 0.00
Checkpoint Therapeutics (CKPT) United States $0.117B 0.00
Lumos Pharma (LUMO) United States $0.115B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.111B 0.00
Cyclerion Therapeutics (CYCN) United States $0.110B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.107B 0.00
Windtree Therapeutics (WINT) United States $0.099B 0.00
Eton Pharmaceuticals (ETON) United States $0.096B 0.00
Oncobiologics (OTLK) United States $0.093B 0.00
SESEN BIO, INC (SESN) United States $0.089B 0.00
Celsion (CLSN) United States $0.088B 0.00
Catalyst Biosciences (CBIO) United States $0.087B 0.00
AquaBounty Technologies (AQB) United States $0.087B 0.00
AnPac Bio-Medical Science (ANPC) China $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
Organovo Holdings (ONVO) United States $0.082B 0.00
Synlogic (SYBX) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.076B 0.00
Stealth BioTherapeutics (MITO) United States $0.069B 0.00
Proteostasis Therapeutics (PTI) United States $0.068B 0.00
DiaMedica Therapeutics (DMAC) United States $0.065B 0.00
Happiness Biotech Group (HAPP) China $0.065B 0.00
Vaccinex (VCNX) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.062B 0.00
Ecology Coatings (ABVC) United States $0.058B 0.00
CollPlant Holdings (CLGN) Israel $0.058B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.056B 0.00
Apricus Biosciences (SEEL) United States $0.055B 0.00
Signal Genetics (MGEN) United States $0.052B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Soligenix (SNGX) United States $0.051B 0.00
Celldex Therapeutics (CLDX) United States $0.051B 0.00
OvaScience (MLND) United States $0.051B 0.00
Cocrystal Pharma (COCP) United States $0.050B 0.00
Prima BioMed (IMMP) Australia $0.048B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.048B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.043B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
Advaxis (ADXS) United States $0.041B 0.00
Cesca Therapeutics (THMO) United States $0.039B 0.00
Chanticleer Holdings (SONN) United States $0.038B 0.00
Acorda Therapeutics (ACOR) United States $0.036B 0.00
ATyr Pharma (LIFE) United States $0.035B 0.00
Curis (CRIS) United States $0.031B 0.00
TrovaGene (CRDF) United States $0.030B 0.00
TOCAGEN INC (TOCA) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Stellar Biotechnologies (EDSA) Canada $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
Alimera Sciences (ALIM) United States $0.025B 0.00
Spherix (AIKI) United States $0.025B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.024B 0.00
Cleveland BioLabs (CBLI) United States $0.023B 0.00
Bionano Genomics (BNGO) United States $0.023B 0.00
Novogen (KZIA) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.022B 0.00
VIVUS (VVUS) United States $0.020B 0.00
Aptevo Therapeutics (APVO) United States $0.018B 0.00
Unum Therapeutics (UMRX) United States $0.017B 0.00
Genetic Technologies (GENE) Australia $0.017B 0.00
TRACON Pharmaceuticals (TCON) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Neuralstem (SNCA) United States $0.009B 0.00
Prana Biotechnology (ATHE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
IMMURON (IMRN) Australia $0.008B 0.00
Sinovac Biotech (SVA) China $0.001B 0.03
Innate Pharma S.A (IPHA) France $0.000B 0.00